Table 3

The associations between LS7 metrics and CVD-related biomarkers in women, n=2775

hsCRP
(mg/L)
D-dimer
(μg/mL)
Fibrinogen
(mg/dL)
Homocysteine
(μmol/L)
hs-cTnT
(ng/L)
NT-ProBNP
(pg/mL)
IL-6*
(pg/mL)
Smoking
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate−0.07
(−0.51, 0.38)
0.11
(−0.22, 0.44)
0.03
(−0.05, 0.11)
0.03
(−0.08, 0.14)
0.005
(−0.17, 0.18)
0.003
(−0.35, 0.36)
0.03
(−0.22, 0.29)
 Ideal0.02
(−0.12, 0.16)
0.03
(−0.07, 0.13)
−0.01
(−0.03, 0.02)
0.08
( 0.11, 0.04)
−0.01
(−0.07, 0.04)
0.07
(−0.04, 0.18)
0.10
( 0.18, 0.02)
Body mass index
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate0.61
( 0.71, 0.51)
0.17
( 0.25, 0.10)
0.08
(0.10, 0.07)
0.04
( 0.07, 0.02)
0.07
( 0.11, 0.03)
0.06
(−0.03, 0.14)
0.34
( 0.40, 0.29)
 Ideal1.15
( 1.25, 1.04)
0.32
( 0.40, 0.23)
0.14
( 0.16, 0.12)
0.06
( 0.08, 0.03)
0.09
( 0.14, 0.05)
0.26
(0.17, 0.35)
0.61
( 0.67, 0.55)
Physical activity
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate−0.06
(−0.19, 0.07)
0.05
(−0.05, 0.15)
0.01
(−0.02, 0.03)
0.03
( 0.07, 0.00)
−0.02
(−0.07, 0.03)
0.01
(−0.09, 0.12)
0.01
(−0.07, 0.08)
 Ideal0.16
( 0.27, 0.06)
−0.04
(−0.11, 0.04)
0.03
( 0.05, 0.02)
−0.02
(−0.05, 0.00)
0.05
( 0.09, 0.005)
0.04
(−0.05, 0.12)
0.10
( 0.16, 0.04)
Diet
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate0.16
( 0.25, 0.07)
−0.02
(−0.09, 0.04)
−0.01
(−0.02, 0.01)
−0.002
(−0.02, 0.02)
−0.01
(−0.05, 0.02)
−0.01
(−0.09, 0.06)
0.10
( 0.15, 0.05)
 Ideal0.40
(−0.74, −0.07)
−0.09
(−0.33, 0.16)
−0.02
(−0.07, 0.04)
−0.07
(−0.16, 0.01)
−0.11
(−0.24, 0.02)
−0.05
(−0.32, 0.21)
0.24
(−0.43, −0.06)
Total cholesterol
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate0.02
(−0.11, 0.14)
−0.04
(−0.13, 0.05)
−0.02
(−0.04, 0.00)
−0.0001
(−0.03, 0.03)
−0.01
(−0.06, 0.04)
0.12
(0.02, 0.21)
0.09
(0.02, 0.16)
 Ideal−0.08
(−0.21, 0.04)
−0.02
(−0.11, 0.08)
0.06
(−0.08, −0.04)
0.01
(−0.02, 0.04)
−0.006
(−0.04, 0.06)
0.24
(0.14, 0.34)
0.13
(0.06, 0.20)
Blood pressure
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate0.13
(−0.24, −0.03)
−0.05
(−0.13, 0.03)
−0.003
(−0.02, 0.02)
−0.005
(−0.03, 0.02)
0.09
(−0.13, −0.04)
0.28
(−0.37, −0.20)
0.07
(−0.13, −0.01)
 Ideal0.45
(−0.56, −0.35)
0.11
(-0.19, −0.03)
0.02
(−0.04, −0.002)
0.04
(−0.07, −0.01)
0.12
(−0.16, −0.08)
0.30
(−0.39, −0.21)
0.21
(−0.27, −0.15)
Blood glucose
 Poor1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)1 (reference)
 Intermediate−0.04
(−0.22, 0.14)
0.01
(−0.13, 0.14)
−0.01
(−0.04, 0.02)
0.04
(−0.01, 0.08)
0.16
(−0.23, −0.09)
0.10
(−0.04, 0.25)
−0.0002
(−0.10, 0.10)
 Ideal0.43
(−0.57, −0.28)
−0.03
(−0.14, 0.08)
0.07
(−0.09, −0.04)
0.002
(−0.03, 0.04)
0.19
(−0.25, −0.13)
0.29
(0.17, 0.40)
0.28
(−0.36, −0.20)
  • *For IL-6, sample size=2733.

  • CVD, cardiovascular disease;hsCRP, high-sensitivity C-reactive protein; hs-cTnT, high-sensitivity cardiac troponin T;IL-6, interleukin 6; LS7, Life’s Simple 7; NT-proBNP, N-terminal pro B-type natriuretic peptide.